Background: To reduce the mortality and morbidity rates of cystic fibrosis (CF) patients, and to have an effective clinical management, it is important to monitor the progression of the disease. The aim of this study was to evaluate the progression of lung disease in CF patients by means of assessing the correlation of the CT scoring system with clinical status and pulmonary function test at the Pediatric Pulmonary Ward of Masih Daneshvari Hospital in 2008. Methods: Pulmonary high resolution computed tomography (HRCT) was performed in 23 CF patients using the Brody's scoring system. Morphologic signs as well as the extent and severity of each sign were scored, and the total score was calculated. The correlation of HRCT scores (total score a...
High‐resolution computed tomography (HRCT) of the chest permits early detection of lung disease; two...
AbstractBackgroundChest imaging is essential in the assessment of respiratory disease in cystic fibr...
The first radiographic scoring system for pulmonary cystic fibrosis was presented in 1958. Since the...
PubMedID: 29976036Background/Aims: Morphological changes due to lung disease in patients with cystic...
textabstractFor effective clinical management of cystic fibrosis (CF) lung disease it is impor...
OBJECTIVE. The objective of our study was to assess the accuracy of one of the most used scoring sys...
Background: A study was undertaken to compare the ability of computed tomographic (CT) scores and pu...
INTRODUCTION: The Shwachman-Kulczycki score was the first scoring system used in cystic fibrosis to ...
International audienceRationale and Objectives: The progressive changes in lung morphology observed ...
Background: Computed tomography (CT) of the lungs is the gold standard for assessing the extent of s...
Objective: to correlate the findings of high resolution computed tomography of the chest based on t...
OBJECTIVE To evaluate whether magnetic resonance imaging (MRI) is effective as computed tomograph...
Background: The dawn of precision medicine and CFTR modulators require more detailed assessment of l...
Cystic fibrosis is the most common lethal autosomal recessive disorder in the Caucasian population. ...
SummaryIntroductionLung disease remains the main cause of morbidity and mortality in patients with C...
High‐resolution computed tomography (HRCT) of the chest permits early detection of lung disease; two...
AbstractBackgroundChest imaging is essential in the assessment of respiratory disease in cystic fibr...
The first radiographic scoring system for pulmonary cystic fibrosis was presented in 1958. Since the...
PubMedID: 29976036Background/Aims: Morphological changes due to lung disease in patients with cystic...
textabstractFor effective clinical management of cystic fibrosis (CF) lung disease it is impor...
OBJECTIVE. The objective of our study was to assess the accuracy of one of the most used scoring sys...
Background: A study was undertaken to compare the ability of computed tomographic (CT) scores and pu...
INTRODUCTION: The Shwachman-Kulczycki score was the first scoring system used in cystic fibrosis to ...
International audienceRationale and Objectives: The progressive changes in lung morphology observed ...
Background: Computed tomography (CT) of the lungs is the gold standard for assessing the extent of s...
Objective: to correlate the findings of high resolution computed tomography of the chest based on t...
OBJECTIVE To evaluate whether magnetic resonance imaging (MRI) is effective as computed tomograph...
Background: The dawn of precision medicine and CFTR modulators require more detailed assessment of l...
Cystic fibrosis is the most common lethal autosomal recessive disorder in the Caucasian population. ...
SummaryIntroductionLung disease remains the main cause of morbidity and mortality in patients with C...
High‐resolution computed tomography (HRCT) of the chest permits early detection of lung disease; two...
AbstractBackgroundChest imaging is essential in the assessment of respiratory disease in cystic fibr...
The first radiographic scoring system for pulmonary cystic fibrosis was presented in 1958. Since the...